CN103948933A - Resveratrol clathrate and preparation method of resveratrol clathrate preparations - Google Patents

Resveratrol clathrate and preparation method of resveratrol clathrate preparations Download PDF

Info

Publication number
CN103948933A
CN103948933A CN201410077746.2A CN201410077746A CN103948933A CN 103948933 A CN103948933 A CN 103948933A CN 201410077746 A CN201410077746 A CN 201410077746A CN 103948933 A CN103948933 A CN 103948933A
Authority
CN
China
Prior art keywords
resveratrol
clathrate
cyclodextrin
preparation
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410077746.2A
Other languages
Chinese (zh)
Inventor
王慧竹
陈帅
薛健飞
陈哲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin Institute of Chemical Technology
Original Assignee
Jilin Institute of Chemical Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin Institute of Chemical Technology filed Critical Jilin Institute of Chemical Technology
Priority to CN201410077746.2A priority Critical patent/CN103948933A/en
Publication of CN103948933A publication Critical patent/CN103948933A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention belongs to the technical field of medicines, and relates to a resveratrol clathrate and a preparation method of resveratrol clathrate preparations, and the method mainly includes the following content: (1) selecting a suitable solvent to dissolve resveratrol; (2) using a modern preparation technology, comprising a saturated water solution method, a grinding method, a freeze drying method, an ultrasonic method, a spray drying method and the like, and a new clathrate material, comprising cyclodextrin or its derivatives such as beta cyclodextrin, hydroxypropyl beta cyclodextrin, alpha cyclodextrin, gamma cyclodextrin, glucosyl beta cyclodextrin and the like, to prepare the resveratrol clathrate; (3) using experiments to optimize a best mass ratio of resveratrol to clathrate material molecule; and (4) preparing the resveratrol clathrate into tablets, capsules, oral liquids and other preparations. By preparation of the resveratrol clathrate and the resveratrol clathrate preparations, the problem of poor water solubility and instability and low bioavailability can be solved.

Description

The preparation method of a kind of resveratrol clathrate and preparation thereof
Technical field
The invention belongs to medical technical field, be specifically related to the preparation method of resveratrol cyclodextrin clathrate and preparation thereof.
Background technology
Resveratrol belongs to polyphenol compound, is called again resvertrol, is mainly derived from the plants such as Fructus Vitis viniferae (red wine), Rhizoma Polygoni Cuspidati, Semen arachidis hypogaeae, Fructus Mori.Resveratrol is a kind of multiple bioactive natural product that has: being not only the chemopreventive agent of tumor, is also to reduce platelet aggregation, the chemopreventive agent of prevention and treatment atherosclerosis, cardiovascular and cerebrovascular disease.Chinese scholars not only has preventive and therapeutic action to cardiovascular disease by studies confirm that resveratrol, and cancer is had to preventive effect equally, especially hormone-dependent tumor is had to obvious preventive effect; In addition resveratrol also has preventive effect to osteoporosis, acne and senile dementia, has antiviral and immunoregulatory pharmacological action.But resveratrol is insoluble in water (dissolubility is 0.03 g/L in water), oral absorption is poor, bioavailability is lower, under ultra-vioket radiation, easily there is isomerization, be difficult to reach the therapeutic effect of expection, therefore utilize new agent technology that it is first made to clathrate, further making various preparations, will greatly improve its stability and bioavailability.
Summary of the invention
The present invention uses modern preparation technique, adopt novel enclose rings of material dextrin or derivatives thereof that its enclose is formed to resveratrol cyclodextrin clathrate, stability and the bioavailability of resveratrol have greatly been improved, and make various dosage forms, enrich the preparation variety of this class medicine, expanded the application prospect of resveratrol.
Technical scheme of the present invention is as follows:
The present invention selects cyclodextrin or derivatives thereof (beta-schardinger dextrin-, HP-β-CD) as enclose material, resveratrol to be made to cyclodextrin clathrate;
Resveratrol cyclodextrin clathrate of the present invention, the mass ratio 1-5:1 of cyclodextrin used and resveratrol, the mass ratio 1-10:1-2 of HP-β-CD and resveratrol;
The preparation of resveratrol clathrate of the present invention: resveratrol, with after suitable organic solvent dissolution, carries out enclose.Solvent used can be ether, chloroform, methanol, ethanol, acetone, ethyl acetate;
The made resveratrol cyclodextrin clathrate of the present invention can be prepared into tablet, capsule, oral liquid;
The invention solves resveratrol water solublity problem, stability and bioavailability improve greatly.
The specific embodiment
Embodiment 1
The preparation of resveratrol clathrate: get 10g beta-schardinger dextrin-and make saturated aqueous solution, magnetic agitation, take resveratrol 5g, after a small amount of anhydrous alcohol solution, slowly splash in above-mentioned beta-schardinger dextrin-saturated aqueous solution, be stirred to the fixed time, after 4 ℃ of cold preservation 24h, decompress filter, a small amount of absolute ethanol washing filter cake, filter cake is dried to constant weight under vacuum, obtains clathrate powder.
Embodiment 2
Supercritical ultrasonics technology is prepared resveratrol clathrate: get 30g beta-schardinger dextrin-and make saturated aqueous solution, add the alcoholic solution of 10g resveratrol, after mixing, by ultrasonic Treatment, will separate out precipitation through solvent wash, dry, obtain clathrate powder.
Embodiment 3
The preparation of resveratrol hydroxypropyl-beta-cyclodextrin inclusion: get HP-β-CD 10g, with after water dissolution, the alcoholic solution of 10 g resveratrols is added, stir, dry, gained solution decompression is dry, obtains white powder hydroxypropyl-beta-cyclodextrin inclusion.
Embodiment 4
The tablet preparation of clathrate: by resveratrol beta-schardinger dextrin-9g, amylum pregelatinisatum 3 g, magnesium stearate is appropriate, mixes gained powder directly compressible.
Embodiment 5
Clathrate hard capsule: after embodiment 4 prescriptions are mixed, gained powder can directly fill hard capsule.
Embodiment 6
Oral resveratrol liquid preparation: by the hydroxypropyl-beta-cyclodextrin inclusion 10g of resveratrol, glucide is dissolved in 90mL water for injection in right amount, and with water for injection standardize solution 100mL processed, mixes, and obtains.

Claims (4)

1. resveratrol cyclodextrin clathrate and a preparation thereof, is characterized in that: utilize cyclodextrin and derivant thereof to improve dissolubility and the stability of resveratrol in water, and make oral formulations.
2. resveratrol clathrate and the preparation thereof of claim 1, wherein cyclodextrin is that beta-schardinger dextrin-, hydroxy propyl-Beta-ring are stuck with paste.
3. resveratrol clathrate according to claim 1 and preparation thereof, is characterized in that: the mass ratio 1-5:1 of cyclodextrin used and resveratrol, the mass ratio 1:10-1:2 of HP-β-CD and resveratrol.
4. resveratrol clathrate according to claim 1 and preparation thereof, is characterized in that: said oral formulations comprises tablet, oral liquid, capsule.
CN201410077746.2A 2014-03-05 2014-03-05 Resveratrol clathrate and preparation method of resveratrol clathrate preparations Pending CN103948933A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410077746.2A CN103948933A (en) 2014-03-05 2014-03-05 Resveratrol clathrate and preparation method of resveratrol clathrate preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410077746.2A CN103948933A (en) 2014-03-05 2014-03-05 Resveratrol clathrate and preparation method of resveratrol clathrate preparations

Publications (1)

Publication Number Publication Date
CN103948933A true CN103948933A (en) 2014-07-30

Family

ID=51326371

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410077746.2A Pending CN103948933A (en) 2014-03-05 2014-03-05 Resveratrol clathrate and preparation method of resveratrol clathrate preparations

Country Status (1)

Country Link
CN (1) CN103948933A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105903033A (en) * 2016-06-21 2016-08-31 重庆医科大学 Resveratrol-sulfobutyl ether-beta-cyclodextrin inclusion compound and preparing method thereof
CN107280988A (en) * 2017-07-03 2017-10-24 李剑峰 Resveratrol cyclodextrin inclusion compound, oligopeptide facial mask liquid and preparation method thereof
CN107281033A (en) * 2017-07-03 2017-10-24 李剑峰 Sleep mask of acne scar acne print and its preparation method and application can be repaired
CN107375047A (en) * 2017-07-03 2017-11-24 李剑峰 Resveratrol cyclodextrin inclusion compound gel and its preparation method and application
EP3603415A1 (en) * 2018-07-30 2020-02-05 Universite D'Avignon et Des Pays Du Vaucluse Method for extracting phenolic compounds
CN111265496A (en) * 2018-12-04 2020-06-12 高雄医学大学 Anti-haze compositions
CN111849021A (en) * 2019-04-28 2020-10-30 南京理工大学 Preparation method of polytetrafluoroethylene/hydroxypropyl-beta-cyclodextrin-resveratrol antioxidant film
CN114304633A (en) * 2022-01-04 2022-04-12 中南大学 Resveratrol-piperine compound microcapsule as well as preparation method and application thereof
CN118021996A (en) * 2024-01-16 2024-05-14 华南理工大学 Antibacterial inclusion material and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1500479A (en) * 2002-11-15 2004-06-02 董英杰 resveratrol , piceid and its derivative and its preparation
CN102429888A (en) * 2011-12-30 2012-05-02 湖南农业大学 Water-soluble resveratrol effervescent tablet and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1500479A (en) * 2002-11-15 2004-06-02 董英杰 resveratrol , piceid and its derivative and its preparation
CN102429888A (en) * 2011-12-30 2012-05-02 湖南农业大学 Water-soluble resveratrol effervescent tablet and preparation method thereof

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105903033A (en) * 2016-06-21 2016-08-31 重庆医科大学 Resveratrol-sulfobutyl ether-beta-cyclodextrin inclusion compound and preparing method thereof
CN107280988A (en) * 2017-07-03 2017-10-24 李剑峰 Resveratrol cyclodextrin inclusion compound, oligopeptide facial mask liquid and preparation method thereof
CN107281033A (en) * 2017-07-03 2017-10-24 李剑峰 Sleep mask of acne scar acne print and its preparation method and application can be repaired
CN107375047A (en) * 2017-07-03 2017-11-24 李剑峰 Resveratrol cyclodextrin inclusion compound gel and its preparation method and application
EP3603415A1 (en) * 2018-07-30 2020-02-05 Universite D'Avignon et Des Pays Du Vaucluse Method for extracting phenolic compounds
WO2020025550A1 (en) * 2018-07-30 2020-02-06 Universite D'avignon Et Des Pays De Vaucluse Method for extraction of phenol compounds
CN111265496A (en) * 2018-12-04 2020-06-12 高雄医学大学 Anti-haze compositions
CN111849021A (en) * 2019-04-28 2020-10-30 南京理工大学 Preparation method of polytetrafluoroethylene/hydroxypropyl-beta-cyclodextrin-resveratrol antioxidant film
CN114304633A (en) * 2022-01-04 2022-04-12 中南大学 Resveratrol-piperine compound microcapsule as well as preparation method and application thereof
CN118021996A (en) * 2024-01-16 2024-05-14 华南理工大学 Antibacterial inclusion material and preparation method and application thereof
CN118021996B (en) * 2024-01-16 2024-07-30 华南理工大学 Antibacterial inclusion material and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN103948933A (en) Resveratrol clathrate and preparation method of resveratrol clathrate preparations
CN105362229A (en) Water-soluble phloretin solid dispersion and preparation method thereof
JP2008208118A (en) Powder composition comprising extract of plant belonging to genus codonopsis
CN101574523A (en) Inclusion compound of water-soluble derivatives of cyclodextrin of volatile oil and preparation method thereof
CN102068494B (en) Health-care capsules with treatment effect on chemical liver injury and preparation method thereof
JP2017012122A (en) Production method of ginger powder processed product and ginger powder processed product
CN102964866A (en) Method for extracting perilla color from perilla leaves
CN106176878A (en) The extracting method of Radix Codonopsis extract
CN105601694B (en) A method of extraction ginsenoside Rg 5
CN103446195A (en) Preparation method of ginkgo biloba extract
tul Kubra et al. Ultrasound-and heat-assisted extraction of glycyrrhizin from licorice by two glycerol-based DESs-Modeling and optimization as per response surface methodology
CN102408464B (en) Triterpene saponins compound and its production and use falls in one
CN106333975A (en) Method for producing brucea javanica micro-capsule particles
JP2007230888A (en) Supplement containing serenoa repens extract and carcinogenesis prophylactic agent
CN101856382B (en) Novel method for extracting and separating platycodin effective ingredients
CN101757105B (en) Extraction method capable of enriching fat soluble and water soluble parts of salvia simultaneously
CN104909995A (en) Chinese magnoliavine fruit lignan single component preparation
CN103570798A (en) Method for producing perilla nankinensis sterol by perilla nankinensis cakes
CN104606519A (en) Novel preparation method of antelope cold preparation
CN104095816A (en) Lutein ester nano particle and preparation method thereof
CN103027930B (en) Biomass composition capable of forming and slowly releasing short-molecular polysaccharide, preparation method and preparation thereof
KR101416673B1 (en) Ginseng prosapogenin high concentration containing ginseng flower preparation using sonication and process for thereof
CN104258108B (en) A kind of preparation method of compound tall gastrodia tuber preparation and the compound tall gastrodia tuber preparation of acquisition
CN102558249A (en) Salvia miltiorrhiza stachyose, and preparation method and application thereof
CN102068648B (en) Health-care capsules with auxiliary treatment effect on alcoholic liver injury and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140730

WD01 Invention patent application deemed withdrawn after publication